- Home
- TMDX vs LU Comparison
TMDX vs LU Comparison
Compare TMDX & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- LU
- Stock Information
- Founded
- TMDX 1998
- LU 2005
- Country
- TMDX United States
- LU China
- Employees
- TMDX N/A
- LU N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LU Finance: Consumer Services
- Sector
- TMDX Health Care
- LU Finance
- Exchange
- TMDX Nasdaq
- LU Nasdaq
- Market Cap
- TMDX 2.1B
- LU 2.4B
- IPO Year
- TMDX 2019
- LU 2020
- Fundamental
- Price
- TMDX $57.20
- LU $2.53
- Analyst Decision
- TMDX Buy
- LU Hold
- Analyst Count
- TMDX 11
- LU 2
- Target Price
- TMDX $116.10
- LU $2.98
- AVG Volume (30 Days)
- TMDX 2.6M
- LU 2.3M
- Earning Date
- TMDX 02-24-2025
- LU 10-21-2024
- Dividend Yield
- TMDX N/A
- LU N/A
- EPS Growth
- TMDX N/A
- LU N/A
- EPS
- TMDX 0.94
- LU N/A
- Revenue
- TMDX $401,090,000.00
- LU $4,671,260,668.00
- Revenue This Year
- TMDX $81.61
- LU N/A
- Revenue Next Year
- TMDX $22.52
- LU $1.48
- P/E Ratio
- TMDX $61.04
- LU N/A
- Revenue Growth
- TMDX 109.09
- LU N/A
- 52 Week Low
- TMDX $56.03
- LU $2.00
- 52 Week High
- TMDX $177.37
- LU $4.94
- Technical
- Relative Strength Index (RSI)
- TMDX 35.74
- LU 55.24
- Support Level
- TMDX $58.40
- LU $2.30
- Resistance Level
- TMDX $67.80
- LU $2.52
- Average True Range (ATR)
- TMDX 4.59
- LU 0.10
- MACD
- TMDX -0.27
- LU 0.02
- Stochastic Oscillator
- TMDX 4.44
- LU 70.31
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About LU Lufax Holding Ltd each representing two (2)
Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.